Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Revenue

In the year 2024, Stoke Therapeutics had annual revenue of $36.56M with 316.34% growth. Stoke Therapeutics had revenue of $22.61M in the quarter ending December 31, 2024, with 707.07% growth.

• Revenue (ttm): $36.56M
• Revenue Growth: +316.34%
• P/S Ratio: 11.45
• Revenue / Employee: $285,586
• Employees: 128
• Market Cap: 419.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.56M	27.78M	316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.